A supplement may tame the Gut-Wrenching side effects of h. pylori therapy
NCT ID NCT07729293
First seen Jul 27, 2026 · Last updated Jul 27, 2026
Summary
This trial tests whether a dietary supplement called Pylori Duo, which contains probiotics and licorice extract, can reduce gastrointestinal side effects from standard H. pylori treatment and help prevent the infection from coming back. About 140 adults with confirmed H. pylori infection will receive standard quadruple therapy plus either Pylori Duo or a placebo for 10 days, followed by the supplement or placebo alone for three months. Researchers will track side effects, eradication rates, and recurrence over a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a dietary supplement containing Lactobacillus rhamnosus and dried licorice extract, called Pylori Duo
- What this could lead to
- If it works, this could point toward a way to make standard H. pylori treatment easier to tolerate and lower the chance of the infection returning.
- What could go wrong
- This is a single-center trial with 140 participants, so results may not apply to everyone. The supplement is tested alongside standard therapy, so its added benefit may be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPEPSIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GALA Laboratories
Don Benito, Badajoz, 06400, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can writing poetry ease anxiety for those with stomach disorders?
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes
- Simpler h. pylori treatment could reduce antibiotic use
- ER study tests which stomach pain remedy works fastest
- AI to predict cancer risk from gut bacteria and scans